Celgene Calls Kyle Bass' AIA Review Bids 'Harassment'
Celgene Corp. on Thursday reinforced its push for sanctions against an organization tied to hedge fund manager Kyle Bass, claiming the group's demand for a review of Celgene's drug patents constitutes...To view the full article, register now.
Already a subscriber? Click here to view full article